HTANALYSTS
HTANALYSTS is an Australian healthcare consultancy providing health technology assessment, HEOR, patient engagement, and SROI impact measurement services to pharmaceutical, medtech, government, and not-for-profit clients across Australia and New Zealand. Founded in 2002, the firm delivers reimbursement submissions, market access strategy, and economic modelling supported by its proprietary Ripple collaboration platform.
- Company typePrivate
- Founded2002
- HeadquartersSurry Hills, Australia
- Headcount11–50
- GTM typeB2B
- OfferingServices
What HTANALYSTS does
HTANALYSTS (legally Health Technology Analysts) is an Australian healthcare consultancy founded in 2002 and headquartered in Surry Hills, NSW, that specialises in health technology assessment (HTA), health economics and outcomes research (HEOR), patient engagement, and social impact measurement. The firm serves pharmaceutical, biotechnology, medical technology, government, and not-for-profit clients in Australia and New Zealand, with services spanning reimbursement submissions to PBAC, MSAC, PHARMAC, and ATAGI; market access strategy; systematic reviews and clinical guideline development; economic modelling; and Social Return on Investment (SROI) analysis delivered through both Premium (end-to-end) and Coached (capability-building) offerings. Its technical differentiator is the proprietary Ripple collaboration platform, a secure outcomes-tracking and team collaboration tool built on Google authentication and security infrastructure, which underpins SROI Coached engagements on a tiered subscription model.
The business operates a professional services revenue model with quote-based project pricing, complemented by structured SROI Coached packages starting at AUD $50,000 for a first project and AUD $100-$300 monthly platform fees for multi-project tiers. Go-to-market is enterprise sales-led, reaching clients through direct business development, professional networks, thought leadership content, and partnerships with bodies such as ISPOR Australian Chapter (including co-hosting the July 2026 AI in Health Innovation event). The firm is privately held following a 2016 management buy-out by owners Alasdair Godfrey (Chief Medical Officer) and Colman Taylor (Chief Vision Officer, Conjoint Associate Professor at UNSW), with a 30+ specialist team supported by a documented track record of 500+ projects, 100+ reimbursement submissions, 70+ systematic reviews, and 50+ peer-reviewed publications. The company also runs a Training Programmes division covering HTA, HEOR, market access, patient engagement, and SROI methodology, delivered in-person or online to clients across APAC.
HTANALYSTS firmographics
Firmographics- Name
- HTANALYSTS
- Legal name
- Health Technology Analysts
- Website
- https://htanalysts.com.au
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- HTANALYSTS is an Australian healthcare consultancy providing health technology assessment, HEOR, patient engagement, and SROI impact measurement services to pharmaceutical, medtech, government, and not-for-profit clients across Australia and New Zealand. Founded in 2002, the firm delivers reimbursement submissions, market access strategy, and economic modelling supported by its proprietary Ripple collaboration platform.
- Ownership category
- akta.pro rank
HTANALYSTS industry classification
Industry- Product category
- Healthcare Consulting
- NAICS
- Marketing Research and Public Opinion Polling (54191)
- SIC
- Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Payer & HTA Engagement (Reimbursement/Submissions) (HLAIAKAD)
- akta.pro secondary industries
- Economic Evaluation & Health Technology Assessment (Public Programs) (HLAJANAL), Market Access, Pricing & Reimbursement (Evidence Generation) FSP (HLAGAOAN)
Keywords
Where HTANALYSTS is headquartered
LocationHeadquarters
- HQ city
- Surry Hills
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
HTANALYSTS business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Health Technology Assessment & HEOR Consulting: Professional consulting services providing health economic evaluation, evidence synthesis, reimbursement submissions (PBAC, MSAC, PHARMAC), market access strategy, and health technology assessment to support funding, policy, and market access decisions.
- Social Impact Assessment Services: SROI (Social Return on Investment) assessment services including Premium (end-to-end delivery) and Coached (capability building support) offerings, along with broader impact assessments for healthcare programmes and government initiatives.
- Healthcare Training Programmes: Expert-led training in HTA, HEOR, market access, patient engagement, and SROI delivered through modular workshops, bespoke programmes, and online learning. Training is offered to pharmaceutical companies, government organisations, healthcare providers, and not-for-profits.
- Patient Engagement Services: Centre of Excellence for Patient Engagement providing advisory boards, patient interviews, journey mapping, support programme design, and advocacy-ready insights to strengthen HTA submissions and policy decisions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | SROI Coached - 1st Project |
| Other | Multi-year contract | SROI Coached - Up to 5 Projects |
| Other | Multi-year contract | SROI Coached - Up to 50 Projects |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels6 records
HTANALYSTS product offering
Product offeringCore offering
HTANALYSTS is a healthcare consultancy delivering health technology assessment (HTA), health economics and outcomes research (HEOR), market access strategy, and reimbursement submission services to pharmaceutical, medical technology, government, and not-for-profit clients. The firm also provides social impact assessment services (including Social Return on Investment), patient engagement advisory through its Centre of Excellence, and structured healthcare training programmes. Its proprietary Ripple collaboration platform supports project delivery and team coordination across these engagements.
Product overview
HTANALYSTS is a leading Australian healthcare consultancy specialising in health technology assessment (HTA), health economics and outcomes research (HEOR), patient engagement, and social impact assessment. The firm operates a portfolio of service offerings built around its core consulting capabilities: Healthcare Services (encompassing evidence evaluation, reimbursement submissions to PBAC/MSAC/PHARMAC, market access strategy, and economic modelling); a dedicated Patient Engagement Centre of Excellence providing advisory boards, journey mapping, and lived experience insights; Social Impact Assessment Services including SROI Premium (full end-to-end assessment) and SROI Coached (capability-building support); the proprietary Ripple collaboration platform for managing impact projects; APAC Training Programmes for building HTA/HEOR/market access skills; and specialist practices in Sustainability, Government Advisory, and Healthy Ageing. These offerings are designed to work synergistically—Ripple underpins SROI delivery, patient engagement strengthens HTA submissions, and training builds market access capability—forming an integrated suite supporting funding, policy, and healthcare decision-making.
Differentiator
Problem solved
Functional benefit
Brands
- Ripple: A powerful and secure collaboration platform that helps track outcomes and drive progress, leveraging Google's security and authentication protocols.
Products and services
- SROI Premium
- SROI Coached
- Ripple Collaboration Platform
- Healthcare Consulting Services
- Patient Engagement Services
- Social Impact Assessment Services
- APAC Training Programmes
- Sustainability Services
- Government Advisory Services
- Healthy Ageing Services
Quantifiable outcome
- Over $3 billion in projected value from new model of care for cardiovascular disease management
- +4 more outcomes
Companies that use HTANALYSTS
Customer profileNamed customers11 records
Segments5 records
Ideal customer profiles5 records
HTANALYSTS technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature1 record
HTANALYSTS partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and key.
- ISPOR Australian ChaptercoreHTANALYSTS has partnered with ISPOR Australian Chapter to co-host the AI in Health Innovation event (July 2026, Sydney). This partnership brings together leading experts across government, industry, and academia to examine AI in health technology assessment, featuring speakers including Prof Toby Walsh, Prof Andrew Wilson, Prof Paul Glasziou, Prof Chris Bain, and Megan Lloyd.
- Thermo Fisher ScientifickeyCommissioned by Thermo Fisher Scientific to conduct modelling assessing the value of rapid Next-Generation Sequencing (NGS) from both health system and patient perspectives. Analysis focused on non-small cell lung cancer (NSCLC) demonstrating cost savings and improved outcomes.
- Novartis PharmaceuticalskeyCollaborated with Novartis Pharmaceuticals and other organisations to co-design a new cardiovascular disease management model (TEST, TREAT, TRACK). HTANALYSTS conducted impact assessment estimating over $3 billion in projected value.
Scale indicators6 records
Recent moves8 records
Expansion highlights6 records
HTANALYSTS competitors and assessment
Company assessmentDirect peers
- Source Health Economics: Independent UK-based health economics and market access consultancy providing HTA submissions, evidence reviews, and economic modelling to pharma and medtech clients. Closely comparable boutique-scale HTA peer.
- Evidera: Pure-play HTA, HEOR, and market access consultancy (now part of Thermo Fisher Scientific's PPD). Closest direct competitor — offers the same reimbursement submission, evidence synthesis, and economic modelling services to pharma and medtech sponsors across global markets.
- RTI Health Solutions: Non-profit HEOR and market access consultancy providing evidence synthesis, economic modelling, and patient-centred research to pharma and device manufacturers. Direct services overlap with HTANALYSTS' HEOR and HTA submission work.
- Mtech Access: UK health economics and market access consultancy delivering HTA submissions (NICE, SMC, NCPE), evidence generation, and patient involvement services. Comparable boutique HTA peer with similar service breadth to HTANALYSTS.
- THEMA Consulting: Norwegian health economics and HTA consultancy providing economic evaluations, reimbursement support, and market access services. Comparable boutique peer with similar service portfolio to HTANALYSTS.
Regional players
- Prospection: Australian health data analytics and real-world evidence company. Regional peer serving Australian pharma and government on market access and evidence generation, overlapping with HTANALYSTS' analytics-heavy work.
Broad incumbents
- IQVIA: Global healthcare data, analytics, and consulting powerhouse. Its Real-World Evidence and HEOR practices compete for the same reimbursement submission and market access budgets as HTANALYSTS but at vastly greater scale and with global delivery capacity.
- PAREXEL International: Large global CRO with dedicated market access and HEOR consulting. Competes for HTA submission work via larger, integrated clinical-plus-commercial engagements.
- Charles River Associates: Global consulting firm with a Life Sciences practice offering HEOR, market access, and pricing strategy to pharma and biotech. Broad incumbent offering comparable reimbursement strategy services.
Emerging players
- Valid Insight: Specialist market access consultancy supporting pharma and medtech clients with HTA submissions and value communication. Emerging boutique peer with similar service positioning.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
HTANALYSTS social profiles
Digital presenceHTANALYSTS financial estimates
Financial estimateRevenue estimate
Valuation estimate
HTANALYSTS leadership team
Management profileNumber of profiles
Profiles11 records
HTANALYSTS funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
HTANALYSTS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about HTANALYSTS
What does HTANALYSTS do?
HTANALYSTS is a healthcare consultancy delivering health technology assessment (HTA), health economics and outcomes research (HEOR), market access strategy, and reimbursement submission services to pharmaceutical, medical technology, government, and not-for-profit clients. The firm also provides social impact assessment services (including Social Return on Investment), patient engagement advisory through its Centre of Excellence, and structured healthcare training programmes. Its proprietary Ripple collaboration platform supports project delivery and team coordination across these engagements.
Is HTANALYSTS a public or private company?
HTANALYSTS is a private company. It is classified as management employee owned and is currently operating.
When was HTANALYSTS founded?
HTANALYSTS was founded in 2002. It employs 11 to 50 people.
Where is HTANALYSTS based?
HTANALYSTS is headquartered in Surry Hills, Australia, in the Oceania region.
How does HTANALYSTS make money?
Four revenue lines are on record. Health Technology Assessment & HEOR Consulting is the primary driver. The others are social Impact Assessment Services, healthcare Training Programmes and patient Engagement Services.
Who are HTANALYSTS's main competitors?
Direct peers on record are Source Health Economics, Evidera, RTI Health Solutions, Mtech Access and THEMA Consulting. Prospection is listed as a regional player. Broad incumbents are IQVIA, PAREXEL International and Charles River Associates. Valid Insight is listed as an emerging player.
Does HTANALYSTS have an API?
No public API is recorded for HTANALYSTS.
What industry is HTANALYSTS in?
HTANALYSTS's product category is Healthcare Consulting. Its primary akta.pro industry code is HLAIAKAD, Payer & HTA Engagement (Reimbursement/Submissions), with a secondary code of HLAJANAL, Economic Evaluation & Health Technology Assessment (Public Programs). Its NAICS code is 54191 and its SIC code is 8000.